Nureca Limited carries a market capitalization of 2.26B, placing it among publicly traded companies globally. Its enterprise value stands at 2.85B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.26B |
| Enterprise Value | 2.85B |
Nureca Limited trades at a trailing price-to-earnings ratio of 250.26.
| PE Ratio | 250.26 |
| PS Ratio | 2.31 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
| EV / Sales | 2.31 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 3,261.81 |
Nureca Limited maintains a current ratio of 27.07, meaning it holds 27.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 5.29, indicating elevated leverage, while an interest coverage ratio of -6.06 demonstrates limited ability to service its debt obligations.
| Current Ratio | 27.07 |
| Quick Ratio | 14.62 |
| Debt / Equity | 5.29 |
| Debt / EBITDA | N/A |
| Interest Coverage | -6.06 |
Over the trailing twelve months, Nureca Limited has paid -420,000.00 in income taxes, reflecting an effective tax rate of 33.96.
| Income Tax | -420,000.00 |
| Effective Tax Rate | 33.96 |
Nureca Limited's stock has declined approximately -20.73231% over the past 52 weeks. The 50-day moving average sits at 253.38, while the 200-day moving average is 267.28.
| Beta (5Y) | N/A |
| 52-Week Price Change | -20.73231% |
| 50-Day Moving Average | 253.38 |
| 200-Day Moving Average | 267.28 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Nureca Limited generated 1.24B in revenue and converted that into -30,000.00 in net income, yielding earnings per share of 0.00. EBITDA reached -79.45M, while operating income came in at -79.45M.
| Revenue | 1.24B |
| Gross Profit | 456.13M |
| Operating Income | -79.45M |
| Pretax Income | -450,000.00 |
| Net Income | -30,000.00 |
| EBITDA | -79.45M |
| EBIT | -79.45M |
| Earnings Per Share (EPS) | 0.00 |
Nureca Limited operates with a gross margin of 36.91, reflecting its pricing power and cost economics. The operating margin of -6.43 and net profit margin of 0.00 provide insight into operational efficiency.
| Gross Margin | 36.91 |
| Operating Margin | -6.43 |
| Pretax Margin | -0.04 |
| Profit Margin | 0.00 |
| EBITDA Margin | -6.43 |
Nureca Limited posts an Altman Z-Score of 21.87, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 21.87 |